PT  - JOURNAL ARTICLE
AU  - Lusa, Lara
AU  - Kappenberg, Franziska
AU  - Collins, Gary S.
AU  - Schmid, Matthias
AU  - Sauerbrei, Willi
AU  - Rahnenführer, Jörg
AU - the Topic Group for High-dimensional data of the STRATOS initiative
TI  - Changes in prediction modelling in biomedicine – do systematic reviews indicate whether there is any trend towards larger data sets and machine learning methods?
AID  - 10.1101/2024.08.09.24311759
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.08.09.24311759
4099  - http://medrxiv.org/content/early/2024/08/10/2024.08.09.24311759.short
4100  - http://medrxiv.org/content/early/2024/08/10/2024.08.09.24311759.full
AB  - The number of prediction models proposed in the biomedical literature has been growing year on year. In the last few years there has been an increasing attention to the changes occurring in the prediction modeling landscape. It is suggested that machine learning techniques are becoming more popular to develop prediction models to exploit complex data structures, higher-dimensional predictor spaces, very large number of participants, heterogeneous subgroups, with the ability to capture higher-order interactions.We examine these changes in modelling practices by investigating a selection of systematic reviews on prediction models published in the biomedical literature. We selected systematic reviews published since 2020 which included at least 50 prediction models. Information was extracted guided by the CHARMS checklist. Time trends were explored using the models published since 2005.We identified 8 reviews, which included 1448 prediction models published in 887 papers. The average number of study participants and outcome events increased considerably between 2015 and 2019, but remained stable afterwards. The number of candidate and final predictors did not noticeably increase over the study period, with a few recent studies using very large numbers of predictors. Internal validation and reporting of discrimination measures became more common, but assessing calibration and carrying out external validation were less common. Information about missing values was not reported in about half of the papers, however the use of imputation methods increased. There was no sign of an increase in using of machine learning methods. Overall, most of the findings were heterogeneous across reviews.Our findings indicate that changes in the prediction modeling landscape in biomedicine are less dramatic than expected and that poor reporting is still common; adherence to well established best practice recommendations from the traditional biostatistics literature is still needed. For machine learning best practice recommendations are still missing, whereas such recommendations are available in the traditional biostatistics literature, but adherence is still inadequate.Competing Interest StatementThe authors have declared no competing interest.Funding StatementYesAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/A Approval not necessary, as it is a re-analysis of systematic review papers.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesData will be available as Supplementary table (included in the submission)